Iridogoniodysgenesis, dominant type
|Iridogoniodysgenesis, dominant type|
|Classification and external resources|
|NCI||Iridogoniodysgenesis, dominant type|
|Patient UK||Iridogoniodysgenesis, dominant type|
Iridogoniodysgenesis, dominant type (type 1, IRID1) refers to a spectrum of diseases characterized by malformations of the irido-corneal angle of the anterior chamber of the eye. Iridogoniodysgenesis is the result of abnormal migration or terminal induction of neural crest cells. These cells lead to formation of most of the anterior segment structures of the eye (corneal stroma & endothelium, iris stroma, trabeculum).
Transmission: autosomal dominant pattern with complete penetrance and variable expressivity.
First reported by Berg (1932).
Treatment: of glaucoma in iridogoniodysgenesis is primarily surgical.
It is listed as a "rare disease" by the Office of Rare Diseases (ORD). This means that Iridogoniodysgenesis, dominant type, or a subtype of Iridogoniodysgenesis, dominant type, affects less than 200,000 people in the US population.